Oral Pharmaceutical composition In Unit dosage form comprising approximately 30 - 37 for Ibandronic Acid or a pharmaceutically acceptable Salt or hydrate thereof,At least 55 to 65 of diluent, 0.5 - 1.5 and a disintegrant

摘要

Oral Pharmaceutical composition In Unit dosage form comprising approximately 30 - 37% for Ibandronic Acid or a pharmaceutically acceptable Salt or hydrate thereof,At least 55 to 65% of diluent, 0.5 - 1.5% of a disintegrant and Lubricant, Preparation procedure, useful for treating osteoporosis and hypercalcemia.